208 related articles for article (PubMed ID: 12605347)
21. [Screening 21-hydroxylase deficiency carriers in androgen excess women of Chinese Han nationality].
Tao H; Lu Z; Zhang B; Wang Y; Sun M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):195-7. PubMed ID: 15793784
[TBL] [Abstract][Full Text] [Related]
22. Genetic defects of steroidogenesis in premature pubarche.
Temeck JW; Pang SY; Nelson C; New MI
J Clin Endocrinol Metab; 1987 Mar; 64(3):609-17. PubMed ID: 3029158
[TBL] [Abstract][Full Text] [Related]
23. The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis.
Ambroziak U; Kępczyńska-Nyk A; Kuryłowicz A; Małunowicz EM; Wójcicka A; Miśkiewicz P; Macech M
Clin Endocrinol (Oxf); 2016 Jan; 84(1):23-9. PubMed ID: 26331608
[TBL] [Abstract][Full Text] [Related]
24. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):396-406. PubMed ID: 27544322
[TBL] [Abstract][Full Text] [Related]
25. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-OHD) in adult males: Clinical presentation, hormone function and the detection of adrenal and testicular adrenal rest tumors (TARTs).
San Martín P; Eugenio Russmann ML; Mendeluk G; Fierro MF; Marino R; Pardes E
Endocrinol Diabetes Nutr (Engl Ed); 2021 Apr; 68(4):227-235. PubMed ID: 34266634
[TBL] [Abstract][Full Text] [Related]
26. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations.
Bachega TA; Brenlha EM; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321
[TBL] [Abstract][Full Text] [Related]
27. Is basal serum 17-OH progesterone a reliable parameter to predict nonclassical congenital adrenal hyperplasia in premature adrenarche?
Gönç EN; Ozön ZA; Alikaşifoğlu A; Engiz O; Bulum B; Kandemir N
Turk J Pediatr; 2011; 53(3):274-80. PubMed ID: 21980808
[TBL] [Abstract][Full Text] [Related]
28. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche.
Armengaud JB; Charkaluk ML; Trivin C; Tardy V; Bréart G; Brauner R; Chalumeau M
J Clin Endocrinol Metab; 2009 Aug; 94(8):2835-40. PubMed ID: 19454583
[TBL] [Abstract][Full Text] [Related]
29. Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test.
Pang S; Carbunaru G; Haider A; Copeland KC; Chang YT; Lutfallah C; Mason JI
Clin Endocrinol (Oxf); 2003 Mar; 58(3):323-31. PubMed ID: 12608938
[TBL] [Abstract][Full Text] [Related]
30. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
Seppel T; Schlaghecke R
Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
[TBL] [Abstract][Full Text] [Related]
31. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.
Knochenhauer ES; Cortet-Rudelli C; Cunnigham RD; Conway-Myers BA; Dewailly D; Azziz R
J Clin Endocrinol Metab; 1997 Feb; 82(2):479-85. PubMed ID: 9024240
[TBL] [Abstract][Full Text] [Related]
32. Five patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (one with associated neuroblastoma) discovered in three generations of one family.
Janjanin N; Dumic M; Skrabic V; Kusec V; Grubic Z; Spehar Uroic A
Horm Res; 2007; 67(3):111-6. PubMed ID: 17057407
[TBL] [Abstract][Full Text] [Related]
33. [Identification of congenital adrenal hyperplasia by measurement of blood-spot 17-hydroxyprogesterone].
Sólyom J; Eckhardt G; Török D
Orv Hetil; 2004 Oct; 145(40):2051-6. PubMed ID: 15559532
[TBL] [Abstract][Full Text] [Related]
34. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
Pang SY; Lerner AJ; Stoner E; Levine LS; Oberfield SE; Engel I; New MI
J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
[TBL] [Abstract][Full Text] [Related]
35. Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations.
Nimkarn S; Cerame BI; Wei JQ; Dumic M; Zunec R; Brkljacic L; Skrabić V; New MI; Wilson RC
J Clin Endocrinol Metab; 1999 Jan; 84(1):378-81. PubMed ID: 9920112
[TBL] [Abstract][Full Text] [Related]
36. An update of congenital adrenal hyperplasia.
New MI
Ann N Y Acad Sci; 2004 Dec; 1038():14-43. PubMed ID: 15838095
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the 21-hydroxylase deficiency and the adrenal functions in young females with Turner syndrome.
Onder A; Aycan Z; Cetinkaya S; Kendirci HN; Bas VN; Agladioglu SY
J Pediatr Endocrinol Metab; 2012; 25(7-8):681-5. PubMed ID: 23155693
[TBL] [Abstract][Full Text] [Related]
38. Congenital adrenal hyperplasia clinical characteristics and genotype in newborn, childhood and adolescence.
Pasqualini T; Alonso G; Tomasini R; Galich AM; Buzzalino N; Fernandez C; Minutolo C; Alba L; Dain L
Medicina (B Aires); 2007; 67(3):253-61. PubMed ID: 17628913
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Forest MG
Hum Reprod Update; 2004; 10(6):469-85. PubMed ID: 15514016
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
